Gilead Sciences
Sustainability Report and Carbon Intensity Rankings
Is Gilead Sciences doing their part?
Their DitchCarbon score is 62
Gilead Sciences has a DitchCarbon Score of 62, indicating a moderate level of sustainability in their operations. This score reflects the company’s efforts to manage and reduce its carbon intensity. A higher score would signify even greater success in minimizing their environmental impact through lower carbon emissions.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Gilead Sciences is part of the industrial manufacturing sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Gilead Sciences operates in the United States, which has a low carbon intensity rating. This suggests that the company’s sustainability efforts are supported by the country’s overall lower environmental impact from energy use.
Unlock 30+ emissions data points on Gilead Sciences
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Gilead Sciences
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
20.71%
...this company is doing 20.71% better in emissions than the industry average.
Gilead Sciences, founded in 1987 and headquartered in Foster City, operates within the biopharmaceutical industry. The company is dedicated to developing and delivering life-saving therapies for a range of illnesses, including HIV/AIDS, liver diseases, cancer, and cardiovascular conditions. With a global staff exceeding 9,000, Gilead Sciences continues to expand its scientific research, boasting 23 marketed products and a robust pipeline of drug candidates.
emission intelligence's platform recommendations for Gilead Sciences
Gilead Sciences should engage with their suppliers to foster the adoption of emissions reduction strategies, which could potentially decrease their emissions by 25% in the purchased goods and services category.
Good news, Gilead Sciences has embraced SBTi commitments
Gilead Sciences has established Science Based Targets initiative (SBTi) commitments to significantly reduce their greenhouse gas emissions from company operations, which include direct emissions and indirect emissions from purchased energy. These commitments align with the global effort to limit temperature rise to 1.5°C above pre-industrial levels, representing a proactive stance in tackling climate change.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.